Similarly, arginase 2 (ARG2) expression has been reported to suppress the proliferation of CD4+ effector T cells and facilitate Treg accumulation by inhibiting the mTOR signaling pathway in metastatic melanoma [37]. Here, ARG2 is linked to metastatic melanoma.